These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8630835)

  • 1. A sociobehavioural perspective on genetic testing and counselling for heritable breast, ovarian and colon cancer.
    Macdonald KG; Doan B; Kelner M; Taylor KM
    CMAJ; 1996 Feb; 154(4):457-64. PubMed ID: 8630835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legal and ethical issues in genetic testing and counseling for susceptibility to breast, ovarian and colon cancer.
    Dickens BM; Pei N; Taylor KM
    CMAJ; 1996 Mar; 154(6):813-8. PubMed ID: 8634959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of the physician in genetic counselling and testing for heritable breast, ovarian and colon cancer.
    Taylor KM; Kelner MJ
    CMAJ; 1996 Apr; 154(8):1155-8. PubMed ID: 8612250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
    Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
    CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.
    Hutson SP
    Oncol Nurs Forum; 2003; 30(2):241-6. PubMed ID: 12692658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A literature review of the psychological impact of genetic testing on breast cancer patients.
    Schlich-Bakker KJ; ten Kroode HF; Ausems MG
    Patient Educ Couns; 2006 Jul; 62(1):13-20. PubMed ID: 16242293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with decisions about clinical BRCA1/2 testing.
    Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scale-up technology: moving predictive tests for inherited breast, ovarian, and colon cancers from the bench to the bedside and beyond.
    Holtzman NA
    J Natl Cancer Inst Monogr; 1995; (17):95-7. PubMed ID: 8573464
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.
    Khabele D; Runowicz CD
    Curr Womens Health Rep; 2002 Jun; 2(3):163-9. PubMed ID: 12099190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.
    Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
    Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients.
    Petersen GM; Larkin E; Codori AM; Wang CY; Booker SV; Bacon J; Giardiello FM; Boyd PA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):337-44. PubMed ID: 10207638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling.
    Decruyenaere M; Evers-Kiebooms G; Denayer L; Welkenhuysen M; Claes E; Legius E; Demyttenaere K
    Eur J Hum Genet; 2000 Feb; 8(2):130-6. PubMed ID: 10757645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health aspects of breast cancer gene testing in Canada. Part 2: selection for and effects of testing.
    Elwood JM
    Chronic Dis Can; 1999; 20(1):14-20. PubMed ID: 10352131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pros and cons of genetic testing for breast and ovarian cancer risk.
    Frank TS; Braverman AM
    Int J Fertil Womens Med; 1999; 44(3):139-45. PubMed ID: 10435912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How interested is the public in genetic testing for colon cancer susceptibility? Report of a cross-sectional population survey.
    Graham ID; Logan DM; Hughes-Benzie R; Evans WK; Perras H; McAuley LM; Laupacis A; Stern H
    Cancer Prev Control; 1998 Aug; 2(4):167-72. PubMed ID: 10093629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testing for breast and ovarian cancer susceptibility: a family experience.
    Van Riper M; McKinnon WC
    J Midwifery Womens Health; 2004; 49(3):210-9. PubMed ID: 15134674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic susceptibility to breast and ovarian cancer: risk assessment, genetic counseling, and management issues.
    Shah MR
    Mo Med; 2004; 101(2):105-10; quiz 110-1. PubMed ID: 15119107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.